Tablet femara

8 Aug 2014 As the tablets contain lactose, Femara is not recommended for patients with rare hereditary problems of galactose intolerance, of severe 15 Apr 2010 Femara (letrozole) 2.5 mg tablets Drug Safety Labeling CHanges March 2010

Find patient medical information for Femara oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings

Femara is a form of hormone therapy known as an aromatase inhibitor, which Femara (letrozole) 2.5 mg tablets are approved for the adjuvant (following Patient information for FEMARA 2.5 MG TABLETS Including dosage instructions and possible side effects The recommended dose of Femara is one 2.5 mg tablet administered once a day, without regard to meals. Other drugs may interact with Femara. Tell your

Femara - Summary of Product Characteristics (SPC) - (eMC)

Label: FEMARA- letrozole tablet, film coated. Label RSS Share. : JavaScript needed for Sharing tools. Share on facebook Share on twitter Bookmark amp Share Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast Femara 2.5 mg oral tablet

19 Nov 2013 Take one 2.5 mg letrozole tablet every day. You can take the tablets before or after meals. The most common side-effects of treatment are hot Letrozole belongs to the group of cancer-fighting medications known as What side effects are possible with Femara 02231384, FEMARA 2.5MG TABLET